siRNA targeting NBS1 or XIAP increases radiation sensitivity of human cancer cells independent of TP53 status

Radiation Research

Volumn 166, Issue 3, 2006, Pages 454-462

  Ohnishi, Ken ^a   Scuric, Zorica ^b   Schiestl, Robert H ^b   Okamoto, Noritomo ^a   Takahashi, Akihisa ^a   Ohnishi, Takeo ^a  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NIBRIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; X LINKED INHIBITOR OF APOPTOSIS;

ARTICLE; CANCER CELL; CELL SURVIVAL; CONTROLLED STUDY; DNA REPAIR; DNA STRAND BREAKAGE; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; NBS1 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIOSENSITIVITY; TP53 GENE; WESTERN BLOTTING; XIAP GENE; YEAST;

CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; GENE SILENCING; GENE TARGETING; HUMANS; NUCLEAR PROTEINS; RADIATION DOSAGE; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

VERTEBRATA;

EID: 33748459890     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3606.1     Document Type: Article

References (38)

1. R. Varon, C. Vissinga, M. Platzer, K. M. Cerosaletti, K. H. Chrzanowska, K. Saar, G. Beckmann, E. Seemanova, P. R. Cooper and A. Reis, Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93, 467-476 (1998).
2. S. Matsuura, H. Tauchi, A. Nakamura, N. Kondo, S. Sakamoto, S. Endo, D. Smeets, B. Solder, B. H. Belohradsky and K. Komatsu, Positional cloning of the gene for Nijmegen breakage syndrome. Nat. Genet. 19, 179-181 (1998).
3. J. P. Carney, R. S. Maser, H. Olivares, E. M. Davis, M. Le Beau, J. R. Yates, 3rd, L. Hays, W. F. Morgan and J. H. Petrini, The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: Linkage of double-strand break repair to the cellular DNA damage response. Cell 93, 477-486 (1998).
4. P. A. Jeggo, Identification of genes involved in repair of DNA double-strand breaks in mammalian cells. Radiat. Res. 150 (Suppl.), S80-S91 (1998).
5. J. E. Haber, Partners and pathways repairing a double-strand break. Trends Genet. 16, 259-264 (2000).
6. P. Karran, DNA double strand break repair in mammalian cells. Curr. Opin. Genet. 10, 144-150 (2000).
7. H. Tauchi, J. Kobayashi, K. Morishima, D. C. van Gent, T. Shiraishi, N. S. Verkaik, D. van Heems, E. Ito, A. Nakamura and K. Komatsu, Nbs1 is essential for DNA repair by homologous recombination in higher vertebrate cells. Nature 420, 93-98 (2002).
8. H. Tauchi, S. Matsuura, J. Kobayashi, S. Sakamoto and K. Komatsu, Nijmegen breakage syndrome gene, NBS1, and molecular links to factors for genome stability. Oncogene 21, 8967-8980 (2002).
9. B. E. Nelms, R. S. Maser, J. F. MacKay, M. G. Lagally and J. H. Petrini, In situ visualization of DNA double-strand break repair in human fibroblasts. Science 280, 590-592 (1998).
10. Y. Zhang, C. U. Lim, E. S. Williams, J. Zhou, Q. Zhang, M. H. Fox, S. M. Bailey and H. L. Liber, NBS1 knockdown by small interfering RNA increases ionizing radiation mutagenesis and telomere association in human cells. Cancer Res. 65, 5544-5553 (2005).
11. J. H. Petrini, The Mre11 complex and ATM: Collaborating to navigate S phase. Curr. Opin. Cell Biol. 12, 293-296 (2000).
12. K. Ohta, A. Nicolas, M. Furuse, A. Nabetani, H. Ogawa and T. Shibata, Mutations in the MRE11, RAD50, XRS2, and MRE2 genes alter chromatin configuration at meiotic DNA double-stranded break sites in premeiotic and meiotic cells. Proc. Natl. Acad. Sci. USA 95, 646-651 (1998).
13. G. E. Taccioli, G. Rathbun, E. Oltz, T. Stamato, P. A. Jeggo and F. W. Alt, Impairment of V(D)J recombination in double-strand break repair mutants. Science 260, 207-210 (1993).
14. E. Harfst, S. Cooper, S. Neubauer, L. Distel and U. Grawunder, Normal V(D)J recombination in cells from patients with Nijmegen breakage syndrome. Mol. Immunol. 37, 915-929 (2000).
15. Y. Peng, Q. Zhang, H. Nagasawa, R. Okayasu, H. L. Liber and J. S. Bedford, Silencing expression of the catalytic subunit of DNA-dependent protein kinase by small interfering RNA sensitizes human cells for radiation-induced chromosome damage, cell killing, and mutation. Cancer Res. 62, 6400-6404 (2002).
16. S. J. Collis, M. J. Swartz, W. G. Nelson and T. L. DeWeese, Enhanced radiation and chemotherapy-mediated cell killing of human cancer cells by small inhibitory RNA silencing of DNA repair factors. Cancer Res. 63, 1550-1554 (2003).
17. J. Bargonetti, P. N. Friedman, S. E. Kern, B. Vogelstein and C. Prives, Wild-type but not mutant TP53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication. Cell 65, 1083-1091 (1991).
18. S. E. Kern, K. W. Kinzler, A. Bruskin, D. Jarosz, P. Friedman, C. Prives and B. Vogelstein, Identification of TP53 as a sequence-specific DNA-binding protein. Science 252, 1708-1711 (1991).
19. H. Ishikawa, N. Mitsuhashi, H. Sakurai, K. Maebayashi and H. Niibe, The effects of TP53 status and human papillomavirus infection on the clinical outcome of patients with stage UIB cervical carcinoma treated with radiation therapy alone. Cancer 91, 80-89 (2001).
20. S. J. Lee, A. Dimtchev, M. F. Lavin, A. Dritschilo and M. Jung, A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-κB. Oncogene 17, 1821-1826 (1998).
21. R. Z. Orlowski and A. S. Baldwin, Jr., NF-κB as a therapeutic target in cancer. Trends Mol. Med. 8, 385-389 (2002).
22. N. Yamagishi, J. Miyakoshi and H. Takebe, Enhanced radiosensitivity by inhibition of nuclear factor kappa B activation in human malignant glioma cells. Int. J. Radiat. Biol. 72, 157-162 (1997).
23. A. S. Baldwin, Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J. Clin. Invest. 107, 241-246 (2001).
24. Y. Habraken, O. Jolois and J. Piette, Differential involvement of the hMRE11/hRAD50/NBS1 complex, BRCA1 and MLH1 in NF-κB activation by camptothecin and X-ray. Oncogene 22, 6090-6099 (2003).
25. E. C. LaCasse, S. Baird, R. G. Korneluk and A. E. MacKenzie, A novel anti-apoptosis gene: The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17, 3247-3259 (1998).
26. I. Tamm, S. Richter, D. Oltersdorf, U. Creutzig, J. Harbott, F. Scholz, L. Karawajew, W. D. Ludwig and C. Wuchter, High expression levels of x-linked inhibitor of apoptosis protein and surviving correlate with poor overall survival in childhood de novo acute myeloid leukemia. Clin. Cancer Res. 10, 3737-3744 (2004).
27. C. Cao, Y. Mu, D. E. Hallahan and B. Lu, XIAP and surviving as therapeutic targets for radiation sensitization in preclinical models of lung cancer. Oncogene 23, 7047-7052 (2004).
28. A. Takahashi, H. Matsumoto, K. Yuki, J. Yasumoto, A. Kajiwara, M. Aoki, Y. Furusawa, K. Ohnishi and T. Ohnishi, High-LET radiation enhanced apoptosis but not necrosis regardless of TP53 status. Int. J. Radiat. Oncol. Biol. Phys. 60, 591-597 (2004).
29. J. Oshima, J. Campisi, T. C. Tannock and G. M. Martin, Regulation of c-fos expression in senescing Werner syndrome fibroblasts differs from that observed in senescing fibroblasts from normal donors. J. Cell. Physiol. 162, 277-283 (1995).
30. V. Ranganathan, W. F. Heine, D. N. Ciccone, K. L. Rudolph, X. Wu, S. Chang, H. Hai, I. M. Ahearn, D. M. Livingston and D. T. Weaver, Rescue of a telomere length defect of Nijmegen breakage syndrome cells requires NBS and telomerase catalytic subunit. Curr. Biol. 11, 962-966 (2001).
31. Y. C. Chen, Y. N. Su, P. C. Chou, W. C. Chiang, M. C. Chang, L. S. Wang, S. C. Teng and K. J. Wu, Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt. J. Biol. Chem. 280, 32505-32511 (2005).
32. K. Ohnishi, I. Ota, A. Takahashi and T. Ohnishi, Glycerol restores TP53-dependent radiosensitivity of human head and neck cancer cells bearing mutant. Br. J. Cancer 83, 1735-1739 (2000).
33. K. Ohnishi, I. Ota, A. Takahashi, K. Yane, H. Matsumoto and T. Ohnishi, Transfection of mutant TP53 gene depresses X-ray- or CDDP-induced apoptosis in a human squamous cell carcinoma of the head and neck. Apoptosis 7, 367-372 (2002).
34. R. G. Bristow, A. Jang, J. Peacock, S. Chung, S. Benchimol and R. P. Hill, Mutant TP53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras. Oncogene 9, 1527-1536 (1994).
35. J. Lotem and L. Sachs, Regulation by bcl-2, c-myc, and TP53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth Differ. 4, 41-47 (1993).
36. J. Lotem and L. Sachs, Control of sensitivity to induction of apoptosis in myeloid leukemic cells by differentiation and bcl-2 dependent and independent pathways. Cell Growth Differ. 5, 321-327 (1994).
37. A. J. McIlwrath, P. A. Vasey, G. M. Ross and R. Brown, Cell cycle arrests and radiosensitivity of human tumor cell lines: Dependence on wild-type TP53 for radiosensitivity. Cancer Res. 54, 3718-3722 (1994).
38. R. Li, P. D. Sutphin, D. Schwartz, D. Matas, N. Almog, R. Wolkowicz, N. Goldfinger, H. Pei, M. Prokocimer and V. Rotter, Mutant TP53 protein expression interferes with TP53-independent apoptotic pathways. Oncogene 16, 3269-3277 (1998).